Viewing StudyNCT00903682


Ignite Creation Date: 2025-12-18 @ 9:03 AM
Ignite Modification Date: 2025-12-23 @ 6:43 PM
Study NCT ID: NCT00903682
Status: None
Last Update Posted: 2013-01-14 00:00:00
First Post: 2009-05-14 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients
Sponsor:
Organization: